Verrica pharmaceuticals inc. (VRCA)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17
ASSETS
Current assets:
Cash and cash equivalents

54,486

9,241

10,600

19,852

24,427

10,271

38,311

103,149

8,663

Marketable securities

33,896

52,776

60,478

58,902

58,855

79,538

-

-

-

Marketable securities

-

-

-

-

-

-

58,664

-

-

Prepaid expenses and other assets

2,265

2,966

2,962

985

1,389

1,343

1,702

1,441

420

Other receivable - related party

-

-

-

-

6

-

-

-

-

Total current assets

90,647

64,983

74,040

79,739

84,677

91,152

98,677

104,590

9,083

Property and equipment, net

2,375

2,090

1,822

1,252

1,013

255

114

112

-

Operating lease right-of-use asset

45

111

178

245

275

-

-

-

-

Other non-current assets

1,375

1,240

-

-

-

-

-

-

-

Deposits

-

-

34

14

14

499

14

14

-

Total assets

94,442

68,424

76,074

81,250

85,979

91,906

98,805

104,716

9,083

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

1,103

1,185

1,010

1,467

1,136

922

1,067

1,081

153

Accrued expenses and other current liabilities

2,066

2,036

-

-

-

-

-

-

-

Accrued expenses

-

-

3,193

2,684

1,804

1,517

1,346

2,008

449

Operating lease liability

133

130

127

124

122

-

-

-

-

Accounts payable and accrued expenses - related party

-

-

-

6

-

38

38

36

14

Total current liabilities

3,302

3,351

4,330

4,281

3,062

2,477

2,451

3,125

616

Operating lease liability

23

58

91

124

156

-

-

-

-

Long-term debt, net

34,434

-

-

-

-

-

-

-

-

Other liabilities

75

-

-

-

-

-

-

-

-

Total liabilities

37,834

3,409

4,421

4,405

3,218

2,477

2,451

3,125

616

Commitments and Contingencies

-

-

-

-

-

-

0

0

-

Convertible preferred stock

-

-

-

-

-

-

-

-

15,508

Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

-

Common stock, $0.0001 par value; 200,000,000 authorized; 25,919,637 shares issued and 25,814,493 shares outstanding as of March 31, 2020 and 25,912,137 shares issued and 25,786,330 shares outstanding as of December 31, 2019

3

3

3

3

3

3

3

3

-

Treasury stock, at cost, 105,144 shares as of March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

Additional paid-in capital

127,599

126,594

125,178

124,269

123,211

122,526

123,365

-

5,394

Subscription receivable

-

410

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

121,856

-

Accumulated deficit

-71,014

-61,192

-53,555

-47,465

-40,464

-33,083

-27,007

-20,268

-12,435

Accumulated other comprehensive gain

20

20

27

38

11

-17

-7

-

-

Total stockholders’ equity

56,608

65,015

71,653

76,845

82,761

89,429

96,354

101,591

-7,041

Total liabilities and stockholders’ equity

94,442

68,424

76,074

81,250

85,979

91,906

98,805

104,716

9,083

Series A Convertible Preferred Stock [Member]
Convertible preferred stock

-

-

-

-

-

-

-

-

10,508

Series B Convertible Preferred Stock [Member]
Convertible preferred stock

-

-

-

-

-

-

-

-

5,000